British
and Irish Legal Information Institute
Freely Available British and Irish Public Legal Information
[
Home]
[
Databases]
[
World Law]
[
Multidatabase Search]
[
Help]
[
Feedback]
United Kingdom Intellectual Property Office Decisions
You are here:
BAILII >>
Databases >>
United Kingdom Intellectual Property Office Decisions >>
Sankyo Company Limited (Patent) [2010] UKIntelP o27110 (5 February 2010)
URL: http://www.bailii.org/uk/cases/UKIntelP/2010/o27110.html
Cite as:
[2010] UKIntelP o27110
[
New search]
[
Printable PDF version]
[
Help]
Sankyo Company Limited [2010] UKIntelP o27110 (5 February 2010)
For the whole decision click here: o27110
Patent decision
- BL number
- O/271/10
- Concerning rights in
- SPC/GB/06/019
- Hearing Officer
- Dr L Cullen
- Decision date
- 5 February 2010
- Person(s) or Company(s) involved
- Sankyo Company Limited
- Provisions discussed
- Council Regulation (EC) No. 469/2009; Article 3 and 10
- Keywords
- Supplementary Protection Certificates
- Related Decisions
- None
Summary
SPC application SPC/GB/06/019, in the name of Sankyo Company Limited, relates to a product defined as “A combination of olmesartan medoxomil, optionally in the form of a pharmaceutically acceptable salt, and hydrochlorothiazide”.
The examiner wrote to the applicant on 20 July 2006 stating that the application did not comply with the requirements of Article 3(a) of Council Regulation (EEC) 1768/92 [now superseded by Council Regulation (EC) 469/2009] because the basic patent EP (UK) 0503785 on which the applicant relies protects only the olmesartan medoxomil component of the applied for product definition. Thus the applied for product is not protected by the basic patent. As a consequence, the examiner indicated that in his opinion the application for a certificate should be refused under Article 10(2) of the Regulation.